Biotech · Private company · New York, NY, US
Coridea, LLC
Track this companyFree. Adds Coridea, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- Cooled RF Bronchoscopic Lung Volume ReductionFiscal year 2026 · $305.4KNIH RePORTER 1R43HL186091-01 · fetched Nov 12, 2026
- Percutaneous Stellate Ganglion Stimulation in Septic Shock to Improve Hemodynamics and Vasopressor Requirements During TransportFiscal year 2026 · $293.8KNIH RePORTER 1R43HL186093-01 · fetched Nov 12, 2026
- ENT-based Approach to Cervical Phrenic Nerve Stimulation for the Treatment of Central Sleep ApneaFiscal year 2026 · $1MNIH RePORTER 5R44HL178050-02 · fetched Nov 12, 2026
- Transcutaneous Phrenic Nerve Stimulation for Treating Opioid OverdoseFiscal year 2026 · $3.4MNIH RePORTER 5UH3DA058439-03 · fetched Nov 12, 2026
- ENT-based Approach to Cervical Phrenic Nerve Stimulation for the Treatment of Central Sleep ApneaFiscal year 2025 · $982.1KNIH RePORTER 1R44HL178050-01 · fetched Nov 12, 2026
- Transcutaneous Phrenic Nerve Stimulation for Treating Opioid OverdoseFiscal year 2025 · $149.9KNIH RePORTER 3UH3DA058439-02S1 · fetched Nov 12, 2026
- Transcutaneous Phrenic Nerve Stimulation for Treating Opioid OverdoseFiscal year 2025 · $2.5MNIH RePORTER 4UH3DA058439-02 · fetched Nov 12, 2026
- Stellate Ganglion Stimulation in Septic Shock to Improve Hemodynamics and Vasopressor RequirementsFiscal year 2024 · $274.8KNIH RePORTER 1R43GM154625-01A1 · fetched Nov 12, 2026
- Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic CardiomyopathyFiscal year 2024 · $122.7KNIH RePORTER 3R44HL167428-02S1 · fetched Nov 12, 2026
- Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic CardiomyopathyFiscal year 2024 · $942KNIH RePORTER 5R44HL167428-02 · fetched Nov 12, 2026